GLUU Glu Mobile Inc.

Design Home Audience Reaches One Million Daily Active Users

Glu Mobile Inc. (NASDAQ: GLUU), a leading global developer and publisher of free-to-play mobile games, today announced that Design Home recently reached one million daily active users. Originally launched worldwide in November 2016, Design Home has achieved remarkable success, having generated more than 25.5 million downloads and $41.4 million in bookings through the end of the second quarter of 2017.

Design Home has achieved rankings of #1 Top Free and #17 Top Grossing game in the U.S. App Store for iPhone. Additionally, Design Home has reached #1 Top Free and #23 Top Grossing game in the U.S. Google Play Store.

“Since launch, Design Home has captivated a large, global audience, many of whom don't normally consider themselves traditional gamers,” said Nick Earl, Glu’s President & CEO. “We’ve invested significantly in building the user base for this title and we’re delighted to be seeing the return on that investment. I’m incredibly proud of the highly engaging content our team continues to deliver for players and look forward to Design Home’s continued success."

About Design Home

Design Home is an interactive platform that brings design dreams to life with a competitive twist! Users have the opportunity to decorate living rooms, dining rooms, bedrooms and outdoor spaces with thousands of furniture and home décor items from today’s leading brands. New challenges are available daily, set against stunning interior spaces from around the world. Design beautiful, unique interiors in this visually stunning 3D experience. Join millions of design and home décor lovers to discover, design, and shop items you love while styling gorgeous rooms and get noticed for your creativity!

Design Home is available for free from the App Store on iPhone, iPad, or iPod touch at http://apple.co/2fDwzRv and on Google Play at http://bit.ly/2f2aGNq.

Cautions Regarding Forward-Looking Statements

This press release contains certain “forward-looking statements” related to the business of Glu Mobile Inc., including statements that we’re delighted to be seeing the return on our investment in building the user base for Design Home and that we look forward to Design Home’s continued success. Such forward-looking statements involve known and unknown risks and uncertainties, including, but not limited to, the risk that we do not continue to realize a sufficient return on our strategic investment in user acquisition for Design Home; the risk that consumer demand for smartphones, tablets and next-generation platforms does not grow as significantly as we anticipate or that we will be unable to capitalize on any such growth; and the risk that we do not realize a sufficient return on our investment with respect to our efforts to develop free-to-play games for smartphones, tablets and next-generation platforms. Certain of these risks and uncertainties are described in greater detail in our public filings with the SEC. Glu is not under obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

About Glu Mobile

Glu Mobile (NASDAQ:GLUU) is a leading global developer and publisher of free-to-play mobile games. Glu is focused on creating compelling original and branded IP games on the App Store, Google Play and Amazon Appstore. Founded in 2001, Glu is headquartered in San Francisco with U.S. offices in Burlingame and San Mateo, and international locations in Canada, India, Japan, and Russia. Consumers can find high-quality entertainment wherever they see the ‘g’ character logo or at www.glu.com.

For live updates, please follow Glu via Twitter at www.twitter.com/glumobile and on Instagram at www.instagram.com/glumobile, or become a Glu fan at www.facebook.com/glumobile.

GLU, GLU MOBILE, and the 'g' character logo are trademarks of Glu Mobile Inc.

EN
28/08/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Glu Mobile Inc.

Wedbush Research
  • Wedbush Research
2454 MEDIATEK CORPORATION
UBI UBISOFT ENTERTAINMENT SA
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
BLUE BLUEBIRD BIO INC.
XOMA XOMA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TPH TRI POINTE HOMES INC.
STX SEAGATE TECHNOLOGY PLC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MGNX MACROGENICS INC.
LGIH LGI HOMES INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
KBH KB HOME
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GME GAMESTOP CORP. CLASS A
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
CCS CENTURY COMMUNITIES INC.
BPMC BLUEPRINT MEDICINES CORP.
BIIB BIOGEN INC.
ATVI ACTIVISION BLIZZARD INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
AMC AMC ENTERTAINMENT HOLDINGS INC. CLASS A
ALXN ALEXION PHARMACEUTICALS INC.
AGTC APPLIED GENETIC TECHNOLOGIES
ABUS ARBUTUS BIOPHARMA CORP.
MRVL MARVELL TECHNOLOGY GROUP LTD.
SWKS SKYWORKS SOLUTIONS INC.
DOOR MASONITE INTERNATIONAL CORP.
5425 TAIWAN SEMICONDUCTOR CO. LTD.
7974 NINTENDO CO. LTD.
BLDR BUILDERS FIRSTSOURCE INC.
EA ELECTRONIC ARTS INC.
GLUU GLU MOBILE INC.
TMHC TAYLOR MORRISON HOME CORPORATION
ZNGA ZYNGA INC. CLASS A
HPE HEWLETT PACKARD ENTERPRISE CO.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ANGI ANGI INC. CLASS A
ARGX ARGEN-X SE
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
AVRO AVROBIO
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
MGTA MAGENTA THERAPEUTICS
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
RGLS REGULUS THERAPEUTICS
TCRR TCR2 THERAPEUTICS
LYFT LYFT
ORTX ORCHARD RX ADS
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
UBER UBER TECHNOLOGIES INC.
IMUX IMMUNIC INC
SCPL SCIPLAY
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
AXLA AXCELLA HEALTH
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
BDTX BLACK DIAMOND THERAPEUTICS
FUSN INC.
U FUSION PHARMACEUTICALS INC
ACET UNITY SOFTWARE INC.
GRAY ADICET BIO
PASG INC
IAC GRAYBUG VISION
FRLN INC
ITOS PASSAGE BIO
INZY IAC/INTERACTIVECORP.
CDAK FREELINE THERAPEUTICS HOLDINGS ADS
ZNTL ITEOS THERAPEUTICS
BEAM INOZYME PHARMA
GBIO CODIAK BIOSCIENCES
PRAX INC.
FHTX ZENTALIS PHARMACEUTICALS
COGT BEAM THERAPEUTICS
TVTX GENERATION BIO
KNTE PRAXIS PRECISION MEDICINES
SKLZ FOGHORN THERAPEUTICS
PLTK INC.
COGENT BIOSCIENCES INC
TRAVERE THERAPEUTICS INC
KINNATE BIOPHARMA
SKILLZ INC (A)
PLAYTIKA HOLDING
Wedbush Research
  • Wedbush Research
2454 MEDIATEK CORPORATION
UBI UBISOFT ENTERTAINMENT SA
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
HZO MARINEMAX INC.
BLUE BLUEBIRD BIO INC.
XOMA XOMA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
STX SEAGATE TECHNOLOGY PLC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NUAN NUANCE COMMUNICATIONS INC.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MGNX MACROGENICS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
INTC INTEL CORPORATION
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
CCS CENTURY COMMUNITIES INC.
BPMC BLUEPRINT MEDICINES CORP.
BIIB BIOGEN INC.
ATVI ACTIVISION BLIZZARD INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ALXN ALEXION PHARMACEUTICALS INC.
AGTC APPLIED GENETIC TECHNOLOGIES
ACOR ACORDA THERAPEUTICS INC.
ABUS ARBUTUS BIOPHARMA CORP.
MRVL MARVELL TECHNOLOGY GROUP LTD.
BC BRUNSWICK CORPORATION
SWKS SKYWORKS SOLUTIONS INC.
5425 TAIWAN SEMICONDUCTOR CO. LTD.
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
GLUU GLU MOBILE INC.
ZNGA ZYNGA INC. CLASS A
HPE HEWLETT PACKARD ENTERPRISE CO.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ARGX ARGEN-X SE
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
AVRO AVROBIO
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
MGTA MAGENTA THERAPEUTICS
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
RGLS REGULUS THERAPEUTICS
TCRR TCR2 THERAPEUTICS
ORTX ORCHARD RX ADS
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
IMUX IMMUNIC INC
SCPL SCIPLAY
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
AXLA AXCELLA HEALTH
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
BDTX BLACK DIAMOND THERAPEUTICS
FUSN INC.
ACET FUSION PHARMACEUTICALS INC
GRAY ADICET BIO
PASG INC
FRLN GRAYBUG VISION
ITOS INC
INZY PASSAGE BIO
CDAK FREELINE THERAPEUTICS HOLDINGS ADS
ZNTL ITEOS THERAPEUTICS
BEAM INOZYME PHARMA
GBIO CODIAK BIOSCIENCES
PRAX INC.
FHTX ZENTALIS PHARMACEUTICALS
COGT BEAM THERAPEUTICS
TVTX GENERATION BIO
KNTE PRAXIS PRECISION MEDICINES
PLTK FOGHORN THERAPEUTICS
INC.
COGENT BIOSCIENCES INC
TRAVERE THERAPEUTICS INC
KINNATE BIOPHARMA
PLAYTIKA HOLDING

ResearchPool Subscriptions

Get the most out of your insights

Get in touch